Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate Augmentation of Citalopram in Geriatric Depression
NCT00602290Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Feb 2008
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate hydrochloride extended-release chewable tablet in major depressive disorder (MDD), sponsored by University of California, Los Angeles. Started Feb 2008; status: completed.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00602290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00602290.